Hepatology ElsewhereFibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half‐OpenedRizvi, Sumera M.B.B.S.; Gores, Gregory J. M.D.Editor(s): Corey, Kathleen E.2; Malhi, Harmeet3 Author Information 1Division of Gastroenterology and HepatologyMayo ClinicRochesterMN 2BostonMA 3RochesterMN Hepatology 68(6):p 2428-2430, December 2018. | DOI: 10.1002/hep.30069 Buy Metrics © 2018 by the American Association for the Study of Liver Diseases.
